FactorPad
Build a Better Process

Stock Risk Measures for Sangamo Therapeutics Inc

A quantitative factor review, as of September 30, 2020.
  1. Company Info - Description, identity and sector data.
  2. Share Data - Stock earnings and key dates.
  3. Market Risk - Beta, size, liquidity and momentum measures.
  4. Financial Risk - Earnings and dividends.
by Paul Alan Davis, CFA
Updated: October 01, 2020
See how we arrive at an overall risk score of 64 for SGMO below.

/ factorpad.com / stocks / f53jfv.html


An ad-free and cookie-free webpage by FactorPad


SGMO Risk Report

Overview

Our quantitative data points are meant to provide a high-level understanding of factors in equity risk models for Sangamo Therapeutics Inc. Portfolio managers use these models to forecast risk, optimize portfolios and review performance.

We show how SGMO stock compares to 2,000+ US-based stocks, and to peers in the Health Technology sector and Biotechnology industry.

Please do not consider this data as investment advice. Data is downloaded from sources we deem reliable, but errors may occur.

Company Info

Business Description

Company logo Sangamo Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the research and development of zinc finger proteins. It focuses on three therapeutic areas: inherited metabolic diseases, central nervous system, and diseases and immunology, which comprises inflammatory and autoimmune diseases. It also offers complementary technology platforms such as gene therapy, ex vivo cell therapy, in vivo genome editing, and in vivo genome regulation. The company was founded by Edward O. Lanphier II in 1995 and is headquartered in Brisbane, CA.

Identity

Sector and Industry

Share Data

Shares and Float

Earnings and Dividends

Market Risk Measures

Many of the following risk metrics are standardized and transformed into quantitative factors in institutional-level risk models.

Rankings below represent percentiles from 1 to 100, with 1 being the lowest rating of risk.

Systematic Risk

Stocks with higher beta exhibit higher sensitivity to the ups and downs in the market. (↑↑)

Company Size

Stocks with higher market capitalization often have lower risk. (↑↓)

Trading Liquidity

Higher average daily dollar volume over the past 30 days implies lower liquidity risk. (↑↓)

Price Momentum

Higher price momentum stocks, aka recent winners, equate to lower risk for many investors. (↑↓)

Financial Risk Measures

Style risk factors often include measures of profitability and payout levels.

Earnings Yield

Companies with higher earnings generally provide lower risk. (↑↓)

Dividend Yield

Companies with higher dividend yields, if sustaintable, are perceived to have lower risk. (↑↓)

/ factorpad.com / stocks / f53jfv.html


SGMO stock risk
SANGAMO THERAPEUTICS INC stock beta
SGMO risk report
SGMO f53jfv
SGMO risk analysis
SGMO volatility
SANGAMO THERAPEUTICS INC credit risk
SGMO liquidity risk
SGMO leverage
SGMO valuation
SGMO systematic risk
SGMO specific risk
SANGAMO THERAPEUTICS INC volatility
SGMO analysis
SGMO financial ratio

This is a new resource, spread the word, tell a friend